Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects
14/09/2026 09:48
BRIEF-Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects Sept 14 (Reuters) - Mabion SA MABP.WA:
SIGNS STATEMENT OF WORK #12 WITH NOVAVAX TO EXPAND COOPERATION UNDER EXISTING MANUFACTURING AGREEMENT
DEAL COVERS IMPLEMENTATION AND PROVISION OF ANALYTICAL SERVICES FOR NOVAVAX'S EARLY-STAGE PIPELINE PROJECTS
Source text: ID:nEM941pM2a
Further company coverage: MABP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects